Ismail Yürekli, Orhan Gökalp, Müge Kiray, Gamze Gökalp, Kazım Ergüneş, Ebru Salman, Banu Şarer Yürekli, Ismail Safa Satoğlu, Yüksel Beşir, Habib Çakır, Ali Gürbüz
Med Sci Monit Basic Res 2013; 19:285-290
The aim of this study was to investigate the protective effects of methylprednisolone (Pn), which is a potent anti-inflammatory agent, and pheniramine maleate (Ph), which is an antihistaminic with some anti-inflammatory effects, on reperfusion injury in brain developing after ischemia of the left lower extremity of rats.
Material and Methods: Twenty-eight randomly selected male Sprague-Dawley rats were divided into 4 groups: Group 1 was the control group, Group 2 was the sham group (I/R), Rats in Group 3 were subjected to I/R and given Ph, and rats in Group 4 were subjected to I/R and given Pn. A tourniquet was applied at the level of left groin region of subjects in the I/R group after induction of anesthesia. One h of ischemia was performed with no drug administration. In the Ph group, half of a total dose of 10 mg/kg Ph was administered intraperitoneally before ischemia and the remaining half before reperfusion. In the Pn group, subjects received a single dose of 50 mg/kg Pn intraperitoneally at the 30th min of ischemia. Brains of all subjects were removed after 24 h for examination.
Results: Malondialdehyde (MDA) levels of the prefrontal cortex were significantly lower in the Ph group than in the I/R group (p<0.05). Superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities were found to be significantly higher in the Ph group than in the I/R group (p<0.05). Histological examination demonstrated that Ph had protective effects against I/R injury developing in the brain tissue.
Conclusions: Ph has a protective effect against ischemia/reperfusion injury created experimentally in rat brains.
Keywords: Brain Injuries - metabolism, Animals, Histamine H1 Antagonists - therapeutic use, In Situ Nick-End Labeling, Malondialdehyde - metabolism, Pheniramine - therapeutic use, Rats, Rats, Sprague-Dawley, Reperfusion Injury - drug therapy